Tailin Biological (300813.SZ) released its first quarter performance, with a net profit attributable to the parent company of 4.8403 million yuan, an increase of 37.19%.

Zhijiao Finance APP News, Tailin Biology (300813.SZ) released its first quarter report for 2026, with the company's operating income at 70.0635 million yuan, a year-on-year increase of 4.67%. The net profit attributable to shareholders of the listed company was 4.8403 million yuan, a year-on-year increase of 37.19%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 4.2055 million yuan, a year-on-year increase of 19.43%. Basic earnings per share was 0.04 yuan.